SALVARANI, CARLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 69.824
EU - Europa 27.896
AS - Asia 27.591
SA - Sud America 4.977
AF - Africa 515
OC - Oceania 157
Continente sconosciuto - Info sul continente non disponibili 51
Totale 131.011
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 68.750
GB - Regno Unito 10.161
SG - Singapore 8.973
CN - Cina 8.133
IT - Italia 5.196
HK - Hong Kong 4.798
BR - Brasile 4.041
SE - Svezia 2.508
DE - Germania 2.227
FI - Finlandia 1.714
VN - Vietnam 1.551
UA - Ucraina 1.530
RU - Federazione Russa 1.392
TR - Turchia 1.242
BG - Bulgaria 768
FR - Francia 608
KR - Corea 585
ID - Indonesia 549
CA - Canada 453
JP - Giappone 392
NL - Olanda 384
IN - India 367
AR - Argentina 348
IE - Irlanda 305
MX - Messico 274
BZ - Belize 221
BD - Bangladesh 180
AT - Austria 175
ES - Italia 170
EC - Ecuador 159
IQ - Iraq 150
ZA - Sudafrica 143
PL - Polonia 133
AU - Australia 127
PK - Pakistan 107
LT - Lituania 106
CO - Colombia 105
EG - Egitto 90
CL - Cile 74
HU - Ungheria 74
VE - Venezuela 74
MA - Marocco 72
CH - Svizzera 68
CZ - Repubblica Ceca 68
BE - Belgio 64
TN - Tunisia 63
PE - Perù 61
MY - Malesia 58
PY - Paraguay 57
IR - Iran 53
UZ - Uzbekistan 49
KE - Kenya 47
SA - Arabia Saudita 40
JO - Giordania 39
AE - Emirati Arabi Uniti 38
EU - Europa 38
PT - Portogallo 34
UY - Uruguay 32
PH - Filippine 30
DZ - Algeria 29
NP - Nepal 29
DK - Danimarca 27
IL - Israele 27
AL - Albania 26
AZ - Azerbaigian 26
NZ - Nuova Zelanda 25
RO - Romania 25
GR - Grecia 24
RS - Serbia 23
TH - Thailandia 22
DO - Repubblica Dominicana 20
TW - Taiwan 19
BO - Bolivia 18
SN - Senegal 18
HN - Honduras 16
OM - Oman 15
JM - Giamaica 14
BH - Bahrain 13
LB - Libano 13
PA - Panama 13
BY - Bielorussia 12
KG - Kirghizistan 12
KZ - Kazakistan 12
GT - Guatemala 11
EE - Estonia 10
NO - Norvegia 10
GE - Georgia 9
NI - Nicaragua 9
SK - Slovacchia (Repubblica Slovacca) 9
SY - Repubblica araba siriana 9
TT - Trinidad e Tobago 9
BB - Barbados 8
CR - Costa Rica 8
LV - Lettonia 8
HR - Croazia 7
LU - Lussemburgo 7
NG - Nigeria 7
PS - Palestinian Territory 7
XK - ???statistics.table.value.countryCode.XK??? 7
GH - Ghana 6
Totale 130.867
Salva come PNG Salva come JPEG
Città #
Fairfield 8.612
Southend 6.696
Santa Clara 6.480
Woodbridge 5.936
Singapore 5.587
Ashburn 5.089
Hong Kong 4.765
Houston 4.078
Chandler 3.411
Seattle 3.177
Wilmington 2.845
Jacksonville 2.765
Cambridge 2.630
Hefei 2.593
Ann Arbor 2.339
London 2.221
Dearborn 1.912
Beijing 1.547
Modena 1.349
Nyköping 1.168
Helsinki 1.128
San Diego 993
Los Angeles 829
Princeton 778
Sofia 750
Chicago 726
New York 726
San Jose 684
The Dalles 667
Dallas 620
Buffalo 572
Eugene 560
Moscow 545
Seoul 544
Ho Chi Minh City 537
Jakarta 434
Izmir 424
Council Bluffs 409
Munich 387
Milan 344
São Paulo 344
Shanghai 339
Hanoi 317
Dublin 276
Salt Lake City 223
Bologna 222
Belize City 221
Redwood City 198
Columbus 196
Tokyo 193
Rome 187
Las Vegas 171
Frankfurt am Main 155
Toronto 146
Boardman 145
Nuremberg 139
Redondo Beach 138
Rio de Janeiro 138
Atlanta 134
Kent 123
Norwalk 108
Falls Church 105
Elk Grove Village 104
Guangzhou 104
Tampa 97
Brooklyn 96
Saint Louis 96
Bremen 95
Parma 92
Brasília 91
Mexico City 90
Nanjing 90
Warsaw 89
Reggio Emilia 86
Orem 85
Belo Horizonte 83
Kilburn 80
Reggio Nell'emilia 79
Lappeenranta 77
Kunming 76
Ankara 73
Boston 72
Denver 71
Haiphong 71
Porto Alegre 70
Albuquerque 69
Florence 69
Vienna 69
Amsterdam 68
Sterling 68
Johannesburg 67
Phoenix 67
Dong Ket 66
San Francisco 65
Jinan 63
Lauterbourg 63
Montreal 61
Curitiba 60
Hounslow 59
Manchester 58
Totale 95.014
Salva come PNG Salva come JPEG
Nome #
Epidemiology and management of interstitial lung disease in ANCA-associated vasculitis 1.237
COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussion 467
Anti-TNF-α drugs differently affect the TNFa-sTNFR system and monocyte subsets in patients with psoriasis 414
Tocilizumab in patients with severe COVID-19: a retrospective cohort study 402
Prevalence of SARS-CoV-2 (Covid-19) in Italians and in immigrants in an area of Northern Italy (Reggio Emilia) 377
Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: The InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device) 359
Validation of the classification criteria for cryoglobulinaemic vasculitis 336
Therapeutic options after treatment failure in rheumatoid arthritis or spondyloarthritides 330
Recommendations for the management of pulmonary fungal infections in patients with rheumatoid arthritis 329
Adult Primary Central Nervous System Vasculitis 324
Combination Therapy with Nintedanib and Sarilumab for the Management of Rheumatoid Arthritis Related Interstitial Lung Disease 309
Corrigendum: Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy 304
Cardio-pulmonary disease management in patients with systemic sclerosis: cardio-rheumatology clinic and patient care standardisation proposal 294
Comment on: Risk factors for severe cranial ischaemic events in an Italian population-based cohort of patients with giant cell arteritis: Reply 292
-463 G/A myeloperoxidase promoter polymorphism in giant cell arteritis 282
INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. WHAT DO WE DON’T KNOW? THE LIRA STUDY (LUNG INVOLVEMENT IN RHEUMATOID ARTHRITIS) 280
Visual loss and other cranial ischaemic complications in giant cell arteritis 279
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register 277
Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature 276
Clinical features of polymyalgia rheumatica and giant cell arteritis 270
(18)F-fluorodeoxyglucose positron emission tomography in the diagnosis and followup of idiopathic retroperitoneal fibrosis 268
An Italian shared dermatological and rheumatological proposal for the use of biological agents in psoriatic disease 266
Rituximab therapy for Takayasu arteritis: A seven patients experience and a review of the literature 266
Ultrasound Examination of Common Carotid Adventitial Thickness Can Differentiate Takayasu Arteritis and Large Vessel Giant Cell Arteritis 265
Empowering Patients in the Therapeutic Decision-Making Process: A Glance Into Behçet's Syndrome 265
Nailfold capillaroscopic changes in dermatomyositis and polymyositis 264
Is duplex ultrasonography useful for the diagnosis of giant-cell arteritis? 263
EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice 262
CC chemokine receptor 5 polymorphism in Italian patients with Behcet's disease 261
G/R 241 polymorphism of intercellular adhesion molecule 1 (ICAM-1) is associated with Fuchs uveitis 260
Role of PD-L1 in licensing immunoregulatory function of dental pulp mesenchymal stem cells 260
Epidemiology of psoriatic arthritis 259
A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility 256
VEXAS Syndrome: A Case Series From a Single-Center Cohort of Italian Patients With Vasculitis 256
Acute-phase reactants and the risk of relapse/recurrence in polymyalgia rheumatica: a prospective followup study 251
Biotherapies in large vessel vasculitis 251
The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria 249
2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative 247
Management of cardiopulmonary disease in patients with systemic sclerosis: cardiorheumatology clinic and patient care standardization proposal 247
Recent advances in the diagnosis and treatment of polymyalgia rheumatica 247
2015 Recommendations for the Management of Polymyalgia Rheumatica: A European League Against Rheumatism/American College of Rheumatology Collaborative Initiative 246
Aortic dilatation in patients with large vessel vasculitis: A longitudinal case control study using PET/CT 245
AB1157 VALIDATION OF VECTOR (VELCRO CRACKLES DETECTOR) FOR THE DIAGNOSIS OF INTERSTITIAL LUNG DISEASE IN PATIENTS WITH CONNECTIVE TISSUE DISEASES 243
2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative 242
Correlations between histopathological findings and clinical manifestations in biopsy-proven giant cell arteritis 242
Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study 241
Thalidomide, deep venous thrombosis and vasculitis 240
Comparison between colour duplex sonography findings and different histological patterns of temporal artery 240
Diagnosis and treatment of rheumatoid arthritis in the Emilia Romagna region: a prospective population-based study 240
Clinical Spectrum of Medium-Sized Vessel Vasculitis 239
Anti-drug antibody detection with label-free electrolyte-gated organic field-effect transistors 239
Biologics in vasculitides: Where do we stand, where do we go from now? 238
Long-term treatment with rituximab in interstitial lung disease related to systemic sclerosis: our clinical experience 237
High-dose glucocorticoids pulse-Therapy for beta-coronaviridae pneumonia: A systematic literature review and case-series of coronavirus disease-2019 236
Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric, nationwide study 235
Comment on: Rituximab therapy for takayasu arteritis: A seven patients experience and a review of the literature: Reply 235
2012 Provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative 234
Predictive factors for partial remission according to the Ankylosing Spondylitis Assessment Study working group in patients with ankylosing spondylitis treated with anti-TNFα drugs 233
[18F]fluorodeoxyglucose positron emission tomography imaging in a case of relapsing polychondritis 233
Infliximab for the treatment of Neuro-Behçet's disease: a case series and review of the literature 232
Contribution of the new 2012 EULAR/ACR classification criteria for the diagnosis of polymyalgia rheumatica 232
Obesity and reduction of the response rate to anti-tumor necrosis factor α in rheumatoid arthritis: an approach to a personalized medicine 231
Interferon Alpha-2a for the Treatment of Post-Infectious Uveitis Secondary to Presumed Intraocular Tuberculosis 230
EULAR guidelines on ANCA-associated vasculitis in the real life 230
Increased expression of interleukin-22 in patients with giant cell arteritis 229
Interstitial pneumonia with autoimmune features: A single center prospective follow-up study 229
Polymyalgia rheumatica 228
Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicenter retrospective study 228
Acute exacerbation of interstitial lung disease associated with rheumatic disease 228
The role of infectious agents in the pathogenesis of vasculitis 227
Contrast-enhanced ultrasound of the carotid artery in patients with large vessel vasculitis: Correlation with positron emission tomography findings 226
Venous Thromboembolism and Cerebrovascular Events in Patients with Giant Cell Arteritis: A Population-Based Retrospective Cohort Study 226
Trial of Tocilizumab in Giant-Cell Arteritis 226
Imaging of vasculitis: State of the art 226
Epidemiology and clinical course of Behçet's disease in the Reggio Emilia area of Northern Italy: a seventeen-year population-based study 226
Use of Neem oil and Hypericum perforatum for treatment of calcinosis-related skin ulcers in systemic sclerosis 225
Polymyalgia rheumatica and giant-cell arteritis 224
Inflamed temporal artery: histologic findings in 354 biopsies, with clinical correlations 223
Remitting seronegative symmetrical synovitis with pitting oedema (RS3PE) syndrome: a prospective follow up and magnetic resonance imaging study 223
Higher Frequencies of Lymphocytes Expressing the Natural Killer Group 2D Receptor in Patients With Behçet Disease 223
Difference in the expression of IL-9 and IL-17 correlates with different histological pattern of vascular wall injury in giant cell arteritis 222
Histopathologic Findings of Patients With Biopsy-Negative Giant Cell Arteritis Compared to Those Without Arteritis: A Population-Based Study 222
anti-TNF agents as therapeutic choice in immune-mediated inflammatory diseases: focus on adalimumab 222
Italian Expert Panel on the management of patients with coexisting spondyloarthritis and inflammatory bowel disease 222
Efficacy of anti-TNF alpha in severe and/or refractory Behçet's disease: Multicenter study of 124 patients 222
The impact of chest CT body composition parameters on clinical outcomes in COVID-19 patients 221
Is colour duplex sonography-guided temporal artery biopsy useful in the diagnosis of giant cell arteritis? A randomized study 221
18F-fluorodeoxyglucose-positron emission tomography: a new explorative perspective 221
Extra-articular manifestations in 587 Italian patients with rheumatoid arthritis 220
Retroperitoneal fibrosis 220
Management of primary and secondary central nervous system vasculitis 220
Giant cell arteritis: Involvement of intracranial arteries 219
Risk factors for severe cranial ischaemic events in an Italian population-based cohort of patients with giant cell arteritis 219
2018 update of the EULAR recommendations for the management of Behçet's syndrome 219
Modulation of Cell Death and Promotion of Chondrogenic Differentiation by Fas/FasL in Human Dental Pulp Stem Cells (hDPSCs) 219
Are steroids alone sufficient for the treatment of giant cell arteritis? 218
Long-term remission in biopsy proven giant cell arteritis: A retrospective cohort study 218
MicroRNA markers of inflammation and remodelling in temporal arteries from patients with giant cell arteritis 218
Complex interplay between neutral and adaptive evolution shaped differential genomic background and disease susceptibility along the Italian peninsula 217
CLINICAL AND PATHOLOGICAL FEATURES OF BREAST CANCER IN PATIENTS WITH SYSTEMIC SCLEROSIS: PRELIMINARY DATA FROM THE SCLERO-BREAST STUDY 217
Totale 26.308
Salva come PNG Salva come JPEG
Categoria #
all - tutte 589.332
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 589.332
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20219.039 0 0 0 0 0 1.125 1.429 1.947 1.016 1.604 919 999
2021/202213.164 620 1.475 1.334 950 369 965 861 631 1.513 943 2.021 1.482
2022/202310.863 1.386 756 738 798 1.307 1.559 243 1.046 1.697 225 597 511
2023/20248.281 335 532 425 849 1.815 486 515 1.469 246 216 374 1.019
2024/202527.331 1.171 353 400 2.006 4.686 4.222 1.655 1.346 3.416 2.343 2.536 3.197
2025/202623.855 3.031 2.057 4.908 5.229 4.620 4.010 0 0 0 0 0 0
Totale 132.952